Williams Jones & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Williams Jones & Associates’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$6.78M	Buy	77,333 +9,284	+14%	+$792K	0.14%	93
2019 Q1	$6.16M	Buy	68,049 +5,678	+9%	+$483K	0.14%	94
2018 Q4	$4.47M	Sell	62,371 -177,193	-74%	-$14.3M	0.12%	113
2018 Q3	$23M	Buy	239,564 +14,706	+7%	+$1.43M	0.46%	59
2018 Q2	$21.4M	Buy	224,858 +48,565	+28%	+$4.46M	0.47%	63
2018 Q1	$15.5M	Buy	176,293 +148,797	+541%	+$13.6M	0.36%	67
2017 Q4	$2.33M	Buy	+27,496	New	+$2.3M	0.05%	172
2015 Q3	–	Sell	-3,990	Closed	-$335K	–	384
2015 Q2	$335K	Hold	3,990	–	–	0.01%	290
2015 Q1	$300K	Sell	3,990 -675	-14%	-$47.2K	0.01%	308
2014 Q4	$290K	Sell	4,665 -450	-9%	-$25.7K	0.01%	310
2014 Q3	$266K	Buy	5,115 +750	+17%	+$38.2K	0.01%	281
2014 Q2	$224K	Sell	4,365 -15,765	-78%	-$711K	0.01%	301
2014 Q1	$956K	Buy	+20,130	New	+$1.03M	0.02%	244

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Williams Jones & Associates's XBI Position: Q2 2019 in Review

Williams Jones & Associates increased its State Street SPDR S&P Biotech ETF (XBI) stake by 14% in Q2 2019, buying an estimated $792K and bringing the position to 77,333 shares worth $6.78M. The position accounts for 0.14% of the portfolio, ranked #93.

Williams Jones & Associates first reported a position in XBI in Q1 2014 and has held it in 13 quarters since. The position peaked at $23M in Q3 2018. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

Williams Jones & Associates held 77,333 shares of State Street SPDR S&P Biotech ETF worth $6.78M as of Q2 2019.
Williams Jones & Associates bought 9,284 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $792K.
State Street SPDR S&P Biotech ETF made up 0.14% of Williams Jones & Associates's portfolio in Q2 2019, its #93 holding.
Williams Jones & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and has held it in 13 quarters since.
Williams Jones & Associates's State Street SPDR S&P Biotech ETF position peaked at $23M in Q3 2018.
424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.